AngioDynamics | ANGO - Gross Profit On Sales


AngioDynamics reported $44.78M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Accuray USD 41.89M 7.42M Dec/2024
AngioDynamics USD 44.78M 2.93M Sep/2025
Artivion USD 73.14M 1.25M Dec/2025
AtriCure USD 109.31M 3.97M Mar/2026
Boston Scientific USD 3.61B 64M Mar/2026
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
ICU Medical USD 202.98M 2.1M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
J&J USD 17.24B 642M Mar/2026
Medtronic USD 6.01B 595M Mar/2026
Merit Medical Systems USD 184.8M 10.56M Mar/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Orthofix International USD 153.28M 4.76M Dec/2025
Smiths GBP 430M 16M Dec/2022
Tandem Diabetes Care USD 167.46M 33.17M Dec/2025
Teleflex USD 307.43M 21K Mar/2026
Terumo JPY 149.02B 4.17B Mar/2026
Trinity Biotech USD 6.47M 1.59M Sep/2025